KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Resmed (RMD) Accumulated Depreciation & Amortization (2016 - 2025)

Resmed's Accumulated Depreciation & Amortization history spans 16 years, with the latest figure at $97.6 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 7.04% year-over-year to $97.6 million; the TTM value through Dec 2025 reached $97.6 million, up 7.04%, while the annual FY2025 figure was $198.5 million, 12.21% up from the prior year.
  • Accumulated Depreciation & Amortization reached $97.6 million in Q4 2025 per RMD's latest filing, up from $47.7 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $198.5 million in Q2 2025 to a low of $36.3 million in Q3 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $96.7 million, with a median of $90.4 million recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: crashed 93.28% in 2021, then skyrocketed 179.86% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $79.9 million in 2021, then tumbled by 52.73% to $37.8 million in 2022, then soared by 137.56% to $89.7 million in 2023, then rose by 1.62% to $91.2 million in 2024, then increased by 7.04% to $97.6 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Accumulated Depreciation & Amortization are $97.6 million (Q4 2025), $47.7 million (Q3 2025), and $198.5 million (Q2 2025).